Showing results (11-20 of 37) with videos related to
Sort By:
Pageof 4
Cell Chemical Biology|November 26, 2024
Covalent targeting of splicing in T cellsKevin A Scott, Hiroyuki Kojima, Nathalie Ropek, et al.Cancer Discovery|January 13, 2021
Serine Biosynthesis Is a Metabolic Vulnerability in FLT3-ITD-Driven Acute Myeloid LeukemiaStefan Bjelosevic, Emily Gruber, Andrea Newbold, et al.Proceedings of the National Academy of Sciences of the United States of America|August 29, 2023
Rationally designed chimeric PI3K-BET bromodomain inhibitors elicit curative responses in MYC-driven lymphomaDanielle H Oh, Xiao Ma, Simon J Hogg, et al.EMBO Molecular Medicine|May 6, 2022
Inhibition of pyrimidine biosynthesis targets protein translation in acute myeloid leukemiaJoan So, Alexander C Lewis, Lorey K Smith, et al.Science Immunology|May 20, 2018
Tumor immune evasion arises through loss of TNF sensitivityConor J Kearney, Stephin J Vervoort, Simon J Hogg, et al.Cell Reports|March 2, 2017
BET-Bromodomain Inhibitors Engage the Host Immune System and Regulate Expression of the Immune Checkpoint Ligand PD-L1Simon J Hogg, Stephin J Vervoort, Sumit Deswal, et al.Nature Immunology|September 22, 2022
NUDT21 limits CD19 levels through alternative mRNA polyadenylation in B cell acute lymphoblastic leukemiaMatthew T Witkowski, Soobeom Lee, Eric Wang, et al.Cell Reports|October 21, 2020
Temporal Analysis of Brd4 Displacement in the Control of B Cell Survival, Proliferation, and DifferentiationIsabella Y Kong, Joel S Rimes, Amanda Light, et al.Cell Reports|February 24, 2024
PRMT1 acts as a suppressor of MHC-I and anti-tumor immunityTirta M Djajawi, Lizzy Pijpers, Akash Srivaths, et al.Cancer Immunology Research|November 16, 2021
BET Inhibition Enhances TNF-Mediated Antitumor ImmunityLisa C Wellinger, Simon J Hogg, Dane M Newman, et al.Pageof 4